The Serum Institute has promised to make 100m doses for Covax of the AstraZeneca vaccine and a further 100m of the Novavax jab – if and when that is approved. The AstraZeneca vaccine accounts for most of it. It is the mainstay of the Covax initiative, which has now bought a total of 1.97bn doses of four different vaccines to distribute when they become available. It aims to provide 3bn doses this year, made in factories around the world under licence. Pfizer offered to sell the vaccine to South Africa at a 50% discounted price of $10 a shot, but was told the cost was still prohibitive.īut Oxford/AstraZeneca’s vaccine is stable at fridge temperatures of 2-8C and AstraZeneca has promised not to make a profit for the duration of the pandemic. Pfizer/BioNTech and Moderna are expensive and need long-term storage at -70C. Three vaccines have been approved in the west. The following day, he clarified the “confusion in the public domain” on Twitter, saying “exports of vaccines are permitted to all countries”.īut the lorries are headed across India for now and the episode underlines the tension as every country with cash wades into the fight for vaccines, putting manufacturers under unprecedented pressure to deliver for them.Īs affluent Europe and North America scramble to deploy the Covid vaccines they have pre-bought – amid accusations that immunisation programmes are too slow and the wrong people are getting the jabs – there has been not a single shot in the arm in many countries elsewhere. Map of factories where the Oxford vaccine will be made
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |